Immunity and Immunotherapy in Inflammatory Bowel Diseases (IBD)

Covers detailed disease mechanisms and the full spectrum of immune cell biology, through to advanced clinical applications The book highlights the latest advances in immunotherapy, including cell-based and next-generation treatments. Immunity and Immunotherapy in Inflammatory Bowel Diseases (IBD): Mechanisms and Innovations bridges laboratory research with clinical practice, addressing diagnostics, biomarkers and real-world patient care. It tackles current challenges in IBD, such as therapy resistance, the integration of AI and multi-omic approaches. What sets this book apart is its extensive, up-to-date coverage of all immunotherapeutic strategies, such as monoclonal antibodies, cytokine inhibitors, JAK inhibitors, cell-based therapies, and novel targets such as CAR-T cells and immune checkpoint modulators. It also addresses emerging technologies, personalized medicine, resistance mechanisms, safety, and the gut microbiome, providing a holistic view of current and future directions in IBD immunotherapy.

• Written and edited by experts in the field, ‘Immunity and Immunotherapy in Inflammatory Bowel Diseases (IBD): Mechanisms and Innovations’ provides comprehensive insights into the immunopathogenesis of IBD
• Offers detailed descriptions of both established and emerging immunotherapies
• Provides a single resource for crucial information on IBD immunity and immunotherapy, from the molecular factors involved to treatment prospects and future directions
• Provides an extensive, up-to-date coverage of all immunotherapeutic strategies, such as monoclonal antibodies, cytokine inhibitors, JAK inhibitors, cell-based therapies, together with novel targets such as CAR-T cells and immune checkpoint modulators